WASHINGTON, Sept 22 (Reuters) - The Trump administration has asked drug companies to be prepared to ramp up production of leucovorin as a treatment for some autism patients, FDA chief Marty Makary told reporters on Monday.
(Reporting by Jeff Mason and Steve Holland; Editing by Chris Reese)
((Steve.a.holland@thomsonreuters.com; www.twitter.com/steveholland1; 202 898 8300; Reuters Messaging: steve.holland.reuters.com@reuters.net))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.